CompanyHRMYNasdaqPlymouth Meeting, PA

Harmony Biosciences Holdings, Inc.

Harmony Biosciences develops therapies for rare neurological diseases.

SEC EDGAR ClinicalTrials.gov ir.harmonybiosciences.com

424B3Sep 11Latest SEC filing

Aug 4Latest story

August 2026

Harmony Biosciences reports record WAKIX revenue, posts Phase 1 data for BP-205

Aug 4Quarterly updateHarmony Biosciences Holdings, Inc.pitolisant

July 2026

Harmony Biosciences preannounces record Q2 2026 revenue, CFO steps down

Jul 16PeopleHarmony Biosciences Holdings, Inc.pitolisant